Lengthy and paper-based admission processes can be simplified and accelerated through automated primary care data transfer, online or app-based registration. This saves time and protects the environment.

During treatment, data can be automated and digitally recorded. This makes the patient history easier to manage and transfer. This promotes the completeness of the history and a decrease in the risk of treatment errors.

By virtually overlaying patient data, organs and vessels, augmented and virtual reality can empower doctors and better design surgeries. Students can benefit from streaming opportunities for learning purposes.

The prices of medicines and generics differ greatly. The political discussion on this points to misaligned incentives in our health care system, which demand new business model solutions from pharmaceutical companies, among others.

Beds and equipment are expensive purchases and are rarely available. A remedy is the digital tracking of beds or expensive equipment. This means increased efficiency in work processes and optimisation in purchasing.

Medicines can work differently depending on the person. Drug development on gene-based therapies enables individualised treatment, greater treatment success, fewer side effects and more satisfied customers.

Analyses of the insured and the use of exchange channels enable the development of new premium systems. Real-time analysis allows you to offer customers exactly the right product they need.

Self-diagnosis is the trend. The increasing number of smart devices enables extensive examination from home. In this way, diseases can be detected before they break out or become acute.

New regulations such as the EDP require networked devices that must both fit into the hospital systems and provide the right interfaces. With the right safety requirements, these are the products of the future.